1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Prostate Specific Antigen (PSA) Testing Market Analysis: By Type (Free PSA Test, Complex PSA Test, Reverse PCR Test); By Geography (North America, Europe, APAC) - Forecast (2015 - 2020)

Prostate Specific Antigen (PSA) Testing Market Analysis: By Type (Free PSA Test, Complex PSA Test, Reverse PCR Test); By Geography (North America, Europe, APAC) - Forecast (2015 - 2020)

  • July 2015
  • -
  • Industry ARC
  • -
  • 180 pages

Summary

Table of Contents

Prostrate Specific Antigen is secreted by epithelial prostatic cells. The primary function of PSA is to break down high molecular weight protein of the seminal coagulum into smaller polypeptides. The PSA is present in serum which is used to detect prostate cancer. There is a continuous circulation of PSA in the blood.

The PSA testing is gaining popularity among clinicians and hospitals as the number of people affected by prostate cancer in the age bracket of 40-50 years is on a rise. A high level of PSA is an indicator of possible prostate cancer. However, there are other physical conditions which might lead to an increase in PSA levels.

The number of people affected by prostate cancer in 2014 was 233,000 from 417,000 in 2012. The reason for this sharp decline in prostate cancer incidences is due to effective PSA testing. The global PSA testing market was close to $250 million in 2014. The population in the age bracket of 50-64 years are more likely to develop prostate cancer. Prostate Cancer is the fourth most common cancer. The need for PSA testing has seen an upward surge. The North America region is going to see the highest increase due to better focus on healthcare. The Europe region has different guidelines and policies for PSA testing in different countries. Such scenario has led to a decreased use of PSA testing in Europe region.

Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the PSA testing market and future opportunities are provided in the report. This report on the global PSA testing market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the PSA testing market.

Please note: this report requires certain updates. We have all the information available but require 2 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Analyze the global prostate cancer market, with important statistics and analysis on existing drugs, and diagnostic technologies. - Receive information on regulatory environment, ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Lung Cancer Statistics in Europe - Forecast

  • April 2017
    10 pages
  • Lung Cancer  

    Therapy  

  • Europe  

View report >

Cancer Statistics - Forecast

  • April 2017
    10 pages
  • Cancer  

  • Europe  

    United Kingdom  

    United States  

View report >

Cancer Statistics

10 days ago

Leukemia Statistics

16 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.